|
a b c d e f g h i j k l m n o p q r s t u v w x y z search |
TeachMeFinance.com - explain IDEC-Y2B8 IDEC-Y2B8 --
An anticancer drug that is a combination of a monoclonal antibody and a radioisotope (yttrium-90). Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells. Also called yttrium Y90 ibritumomab tiuxetan.
|